Symbols / PHAR Stock $16.92 -0.94% Pharming Group N.V.

Healthcare • Biotechnology • Netherlands • NGM
PHAR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K? inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Stock Fundamentals
Scroll to Statements
Market Cap 1.19B Enterprise Value 11.92B Income 2.85M Sales 376.13M Book/sh 3.95 Cash/sh 0.26
Dividend Yield — Payout 0.00% Employees 407 IPO — P/E 423.00 Forward P/E 46.10
PEG — P/S 3.18 P/B 4.28 P/C — EV/EBITDA 300.93 EV/Sales 31.69
Quick Ratio 1.97 Current Ratio 2.59 Debt/Eq 41.78 LT Debt/Eq — EPS (ttm) 0.04 EPS next Y 0.37
EPS Growth 104.20% Revenue Growth 15.00% Earnings 2026-03-12 ROA 4.55% ROE 1.02% ROIC —
Gross Margin 87.90% Oper. Margin 2.84% Profit Margin 0.76% Shs Outstand 70.63M Shs Float 690.78M Short Float 0.02%
Short Ratio 0.54 Short Interest — 52W High 21.34 52W Low 8.26 Beta 0.12 Avg Volume 25.59K
Volume 887.00 Target Price $34.60 Recom Strong_buy Prev Close $17.08 Price $16.92 Change -0.94%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$34.60
Mean price target
2. Current target
$16.92
Latest analyst target
3. DCF / Fair value
$17.50
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$16.92
Low
$23.40
High
$41.00
Mean
$34.60

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-10 init Canaccord Genuity — → Buy $37
2026-03-24 reit HC Wainwright & Co. Buy → Buy $37
2026-03-13 reit Oppenheimer Outperform → Outperform $41
2025-03-21 reit HC Wainwright & Co. Buy → Buy $37
2025-03-20 reit HC Wainwright & Co. Buy → Buy $37
2025-03-14 main Oppenheimer Outperform → Outperform $39
2025-03-14 reit HC Wainwright & Co. Buy → Buy $37
2024-12-17 reit HC Wainwright & Co. Buy → Buy $37
2024-12-16 reit HC Wainwright & Co. Buy → Buy $37
2024-12-11 reit HC Wainwright & Co. Buy → Buy $37
2024-12-09 init Jefferies — → Buy $14
2024-10-28 main Oppenheimer Outperform → Outperform $30
2024-10-24 reit HC Wainwright & Co. Buy → Buy $37
2024-10-15 reit HC Wainwright & Co. Buy → Buy $37
2024-10-10 reit HC Wainwright & Co. Buy → Buy $37
2024-09-26 reit HC Wainwright & Co. Buy → Buy $37
2024-08-01 reit HC Wainwright & Co. Buy → Buy $37
2024-05-31 reit HC Wainwright & Co. Buy → Buy $37
2024-03-14 reit HC Wainwright & Co. Buy → Buy $37
2023-08-03 reit HC Wainwright & Co. — → Buy $37
News
RSS: Latest PHAR news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
376.13
+26.56%
297.20
+21.15%
245.32
+19.30%
205.62
Operating Revenue
376.13
+26.56%
297.20
+21.15%
245.32
+19.30%
205.62
Cost Of Revenue
45.50
+28.53%
35.40
+40.41%
25.21
+43.56%
17.56
Reconciled Cost Of Revenue
43.49
+51.60%
28.69
+55.56%
18.44
+59.98%
11.53
Gross Profit
330.63
+26.29%
261.80
+18.94%
220.10
+17.04%
188.06
Operating Expense
309.75
+16.68%
265.47
+9.52%
242.39
+36.02%
178.20
Research And Development
100.37
+20.71%
83.15
+20.65%
68.91
+31.19%
52.53
Selling General And Administration
117.44
+18.36%
99.22
+13.39%
87.50
+27.08%
68.85
Selling And Marketing Expense
6.66
-6.73%
7.13
+4.66%
6.82
+6.35%
6.41
General And Administrative Expense
110.78
+20.31%
92.08
+14.13%
80.68
+29.21%
62.44
Salaries And Wages
92.51
+24.47%
74.32
+13.13%
65.69
+37.65%
47.73
Other Gand A
18.27
+2.87%
17.76
+18.51%
14.99
+1.85%
14.72
Other Operating Expenses
82.74
+12.20%
73.74
-4.01%
76.82
+54.69%
49.66
Total Expenses
355.25
+18.08%
300.87
+12.43%
267.61
+36.70%
195.76
Operating Income
20.88
+669.74%
-3.67
+83.56%
-22.29
-326.05%
9.86
Total Operating Income As Reported
25.84
+399.76%
-8.62
-60.03%
-5.39
-129.55%
18.23
EBITDA
34.78
+113.19%
16.32
+65.18%
9.88
-70.55%
33.53
Normalized EBITDA
36.28
+152.50%
14.37
+606.24%
-2.84
-112.64%
22.45
Reconciled Depreciation
11.22
-30.21%
16.07
+0.91%
15.93
+20.75%
13.19
EBIT
23.57
+9518.78%
0.24
+104.05%
-6.05
-129.73%
20.34
Total Unusual Items
-1.49
-176.69%
1.95
-84.68%
12.71
+14.75%
11.08
Total Unusual Items Excluding Goodwill
-1.49
-176.69%
1.95
-84.68%
12.71
+14.75%
11.08
Special Income Charges
3.39
+167.36%
-5.03
-130.25%
16.62
+111.24%
7.87
Other Special Charges
-3.88
—
—
—
Impairment Of Capital Assets
0.49
-90.23%
5.03
+7.81%
4.66
+6.56%
4.38
Restructuring And Mergern Acquisition
—
—
—
0.00
Net Income
2.85
+124.08%
-11.84
-12.26%
-10.55
-177.14%
13.67
Pretax Income
12.85
+251.28%
-8.49
+29.30%
-12.01
-180.15%
14.99
Net Non Operating Interest Income Expense
-8.74
-71.82%
-5.09
-108.87%
-2.44
+54.72%
-5.38
Interest Expense Non Operating
10.72
+22.69%
8.74
+46.50%
5.96
+11.31%
5.36
Net Interest Income
-8.74
-71.82%
-5.09
-108.87%
-2.44
+54.72%
-5.38
Interest Expense
10.72
+22.69%
8.74
+46.50%
5.96
+11.31%
5.36
Interest Income Non Operating
2.18
-55.21%
4.86
+32.62%
3.66
+4209.41%
0.09
Interest Income
2.18
-55.21%
4.86
+32.62%
3.66
+4209.41%
0.09
Other Income Expense
0.70
+171.81%
0.26
-97.96%
12.71
+21.01%
10.51
Other Non Operating Income Expenses
1.57
+2118.31%
0.07
-75.17%
0.29
-43.59%
0.51
Gain On Sale Of Security
-4.88
-169.96%
6.97
+278.80%
-3.90
-221.34%
3.21
Gain On Sale Of Business
—
0.00
0.00
-100.00%
12.24
Tax Provision
10.31
+207.85%
3.35
+328.76%
-1.46
-211.50%
1.31
Tax Rate For Calcs
0.00
+0.00%
0.00
+111.69%
0.00
+39.12%
0.00
Tax Effect Of Unusual Items
-0.39
-176.69%
0.50
-67.57%
1.55
+59.63%
0.97
Net Income Including Noncontrolling Interests
2.54
+121.43%
-11.84
-12.26%
-10.55
-177.14%
13.67
Net Income From Continuing Operation Net Minority Interest
2.85
+124.08%
-11.84
-12.26%
-10.55
-177.14%
13.67
Net Income From Continuing And Discontinued Operation
2.85
+124.08%
-11.84
-12.26%
-10.55
-177.14%
13.67
Net Income Continuous Operations
2.54
+121.43%
-11.84
-12.26%
-10.55
-177.14%
13.67
Minority Interests
0.31
0.00
0.00
—
Normalized Income
3.96
+129.80%
-13.29
+38.81%
-21.71
-709.27%
3.56
Net Income Common Stockholders
2.85
+124.08%
-11.84
-12.26%
-10.55
-177.14%
13.67
Diluted EPS
0.04
+122.22%
-0.18
-20.00%
-0.15
-178.95%
0.19
Basic EPS
0.04
+122.22%
-0.18
-20.00%
-0.15
-171.43%
0.21
Basic Average Shares
68.88
+2.60%
67.13
-0.48%
67.46
+3.60%
65.11
Diluted Average Shares
74.69
-4.91%
78.54
+16.43%
67.46
-6.26%
71.97
Diluted NI Availto Com Stockholders
2.85
+124.08%
-11.84
-12.26%
-10.55
-177.14%
13.67
Amortization
6.29
+4.04%
6.04
+7.20%
5.63
+32.37%
4.26
Amortization Of Intangibles Income Statement
6.29
+4.04%
6.04
+7.20%
5.63
+32.37%
4.26
Depreciation Amortization Depletion Income Statement
9.21
-1.62%
9.36
+2.24%
9.16
+27.98%
7.15
Depreciation And Amortization In Income Statement
9.21
-1.62%
9.36
+2.24%
9.16
+27.98%
7.15
Depreciation Income Statement
2.92
-11.93%
3.32
-5.71%
3.52
+21.54%
2.90
Earnings From Equity Interest
0.62
+135.40%
-1.76
-509.00%
-0.29
+73.31%
-1.08
Gain On Sale Of PPE
0.00
0.00
-100.00%
21.28
0.00
Total Other Finance Cost
0.20
-83.76%
1.21
+800.75%
0.13
+27.62%
0.10
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
499.96
+25.00%
399.99
-13.58%
462.85
+8.70%
425.80
Current Assets
299.47
+7.55%
278.44
-11.98%
316.34
+14.00%
277.50
Cash Cash Equivalents And Short Term Investments
179.10
+6.68%
167.89
-21.33%
213.42
+2.93%
207.34
Cash And Cash Equivalents
145.31
+164.46%
54.94
-11.01%
61.74
-70.22%
207.34
Other Short Term Investments
33.80
-70.08%
112.95
-25.54%
151.68
0.00
Receivables
48.44
-3.45%
50.17
+17.73%
42.62
+68.23%
25.33
Accounts Receivable
41.77
+0.57%
41.53
+17.29%
35.41
+68.90%
20.96
Other Receivables
1.93
+21.05%
1.60
-25.59%
2.15
+92.03%
1.12
Taxes Receivable
4.74
-32.69%
7.04
+39.17%
5.06
+55.75%
3.25
Inventory
64.90
+16.47%
55.72
-1.83%
56.76
+34.10%
42.33
Raw Materials
0.00
-100.00%
0.42
-39.72%
0.70
+125.24%
0.31
Work In Process
46.69
+19.71%
39.00
+3.44%
37.71
+27.59%
29.55
Finished Goods
18.21
+11.76%
16.30
-11.18%
18.35
+47.26%
12.46
Prepaid Assets
6.26
+34.66%
4.65
+31.27%
3.54
+54.85%
2.29
Restricted Cash
0.76
0.00
0.00
-100.00%
0.21
Other Current Assets
0.00
—
—
—
Total Non Current Assets
200.50
+64.96%
121.55
-17.04%
146.51
-1.20%
148.30
Net PPE
23.97
-0.68%
24.13
-27.89%
33.47
-14.51%
39.15
Gross PPE
60.40
+11.68%
54.08
-10.45%
60.40
+2.14%
59.13
Accumulated Depreciation
-36.43
-21.63%
-29.95
-11.21%
-26.93
-34.73%
-19.99
Properties
0.00
0.00
0.00
0.00
Land And Improvements
—
—
0.00
0.00
Buildings And Improvements
27.95
+13.91%
24.53
-20.75%
30.96
-5.85%
32.88
Machinery Furniture Equipment
19.93
+7.25%
18.59
+0.03%
18.58
+14.20%
16.27
Construction In Progress
0.00
-100.00%
0.14
-18.99%
0.18
+2883.33%
0.01
Other Properties
6.12
+13.58%
5.38
+4.93%
5.13
+9.38%
4.69
Leases
6.40
+17.88%
5.43
-2.06%
5.55
+5.00%
5.28
Goodwill And Other Intangible Assets
135.54
+122.05%
61.04
-14.35%
71.27
-5.13%
75.12
Goodwill
3.32
0.00
—
—
Other Intangible Assets
132.22
+116.61%
61.04
-14.35%
71.27
-5.13%
75.12
Investments And Advances
8.65
+104.28%
4.23
-59.29%
10.40
+6.85%
9.73
Long Term Equity Investment
1.94
+317.17%
0.47
-79.61%
2.29
-8.64%
2.50
Non Current Deferred Assets
31.02
+1.55%
30.54
+2.63%
29.76
+29.55%
22.97
Non Current Deferred Taxes Assets
31.02
+1.55%
30.54
+2.63%
29.76
+29.55%
22.97
Non Current Prepaid Assets
0.09
+4.44%
0.09
-2.17%
0.09
-59.65%
0.23
Other Non Current Assets
1.23
-18.41%
1.50
-1.51%
1.53
+39.04%
1.10
Total Liabilities Net Minority Interest
222.86
+24.56%
178.92
-26.69%
244.07
+10.36%
221.16
Current Liabilities
115.79
+56.89%
73.80
-5.34%
77.97
+30.60%
59.70
Payables And Accrued Expenses
105.90
+58.98%
66.61
-8.16%
72.53
+33.16%
54.47
Payables
14.59
+8.97%
13.39
-39.85%
22.26
+105.09%
10.85
Accounts Payable
8.54
-15.42%
10.10
-36.94%
16.02
+83.05%
8.75
Other Payable
—
—
—
—
Current Accrued Expenses
91.31
+71.56%
53.22
+5.87%
50.27
+15.27%
43.61
Total Tax Payable
6.04
+84.01%
3.28
-47.32%
6.23
+197.00%
2.10
Current Debt And Capital Lease Obligation
8.71
+21.05%
7.19
+32.19%
5.44
+3.96%
5.23
Current Debt
5.34
+25.70%
4.25
+132.73%
1.82
+3.17%
1.77
Other Current Borrowings
5.34
+25.70%
4.25
+132.73%
1.82
+3.17%
1.77
Current Capital Lease Obligation
3.37
+14.36%
2.95
-18.53%
3.62
+4.36%
3.46
Other Current Liabilities
-0.00
—
—
—
Total Non Current Liabilities Net Minority Interest
107.07
+1.85%
105.12
-36.71%
166.10
+2.88%
161.46
Long Term Debt And Capital Lease Obligation
107.07
+1.85%
105.12
-36.71%
166.10
+2.88%
161.46
Long Term Debt
92.72
+18.64%
78.15
-42.79%
136.60
+3.78%
131.62
Long Term Capital Lease Obligation
14.35
-46.79%
26.97
-8.60%
29.51
-1.13%
29.84
Other Non Current Liabilities
—
—
—
—
Stockholders Equity
277.10
+25.35%
221.06
+1.04%
218.78
+6.91%
204.64
Common Stock Equity
277.10
+25.35%
221.06
+1.04%
218.78
+6.91%
204.64
Capital Stock
8.01
+3.09%
7.77
+1.30%
7.67
+2.13%
7.51
Common Stock
8.01
+3.09%
7.77
+1.30%
7.67
+2.13%
7.51
Share Issued
701.68
+3.14%
680.31
+1.38%
671.07
+2.24%
656.35
Ordinary Shares Number
701.68
+3.14%
680.31
+1.38%
671.07
+2.24%
656.35
Additional Paid In Capital
513.26
+4.96%
488.99
+2.21%
478.43
+3.49%
462.30
Retained Earnings
-272.98
+0.91%
-275.49
-3.86%
-265.26
-3.44%
-256.43
Gains Losses Not Affecting Retained Earnings
28.82
+13889.00%
-0.21
+89.84%
-2.06
+76.46%
-8.74
Minority Interest
0.00
0.00
—
—
Other Equity Adjustments
28.82
+13889.00%
-0.21
+89.84%
-2.06
+76.46%
-8.74
Total Equity Gross Minority Interest
277.10
+25.35%
221.06
+1.04%
218.78
+6.91%
204.64
Total Capitalization
369.82
+23.60%
299.21
-15.80%
355.38
+5.69%
336.26
Working Capital
183.68
-10.24%
204.64
-14.15%
238.37
+9.45%
217.80
Invested Capital
375.16
+23.63%
303.46
-15.05%
357.20
+5.67%
338.02
Total Debt
115.78
+3.08%
112.31
-34.53%
171.54
+2.91%
166.69
Net Debt
—
27.45
-64.20%
76.68
—
Capital Lease Obligations
17.72
-40.76%
29.91
-9.69%
33.12
-0.56%
33.31
Net Tangible Assets
141.56
-11.53%
160.02
+8.48%
147.51
+13.90%
129.52
Tangible Book Value
141.56
-11.53%
160.02
+8.48%
147.51
+13.90%
129.52
Available For Sale Securities
—
—
2.02
+401.24%
0.40
Current Provisions
1.19
—
—
—
Financial Assets Designatedas Fair Value Through Profitor Loss Total
6.70
+77.94%
3.77
-38.17%
6.09
-10.75%
6.83
Investmentin Financial Assets
6.70
+77.94%
3.77
-53.57%
8.11
+12.21%
7.23
Investments In Other Ventures Under Equity Method
—
—
—
2.50
Investmentsin Associatesat Cost
1.94
+317.17%
0.47
-79.61%
2.29
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
54.71
+3147.80%
-1.79
+89.63%
-17.30
-177.04%
22.46
Cash Flow From Continuing Operating Activities
54.71
+3147.80%
-1.79
+89.63%
-17.30
-177.04%
22.46
Net Income From Continuing Operations
12.85
+251.28%
-8.49
+29.30%
-12.01
-180.15%
14.99
Depreciation Amortization Depletion
11.22
-30.21%
16.07
+0.91%
15.93
+20.75%
13.19
Depreciation
11.22
-30.21%
16.07
+0.91%
15.93
+20.75%
13.19
Depreciation And Amortization
11.22
-30.21%
16.07
+0.91%
15.93
+20.75%
13.19
Other Non Cash Items
13.38
+787.56%
-1.95
-137.02%
5.26
+795.57%
0.59
Stock Based Compensation
13.77
+22.39%
11.25
+21.59%
9.25
+44.73%
6.39
Operating Gains Losses
-4.36
-344.72%
1.78
+108.48%
-20.99
-88.10%
-11.16
Gain Loss On Investment Securities
-2.35
+53.01%
-4.99
-636.56%
0.93
-21.52%
1.19
Gain Loss On Sale Of PPE
—
0.02
0.00
0.00
Change In Working Capital
10.38
+203.11%
-10.07
+40.62%
-16.96
-4282.69%
-0.39
Change In Receivables
-3.35
+50.54%
-6.78
+63.41%
-18.54
-884.22%
2.36
Change In Inventory
-1.29
-156.06%
-0.50
+96.52%
-14.43
+3.88%
-15.02
Change In Payables And Accrued Expense
14.13
+610.15%
-2.77
-117.06%
16.23
+35.32%
11.99
Change In Payable
14.13
+610.15%
-2.77
-117.06%
16.23
+35.32%
11.99
Change In Other Working Capital
0.90
+5405.88%
-0.02
+92.13%
-0.22
-179.12%
0.27
Investing Cash Flow
26.25
-16.97%
31.62
+124.44%
-129.39
-2530.73%
5.32
Cash Flow From Continuing Investing Activities
26.25
-16.97%
31.62
+124.44%
-129.39
-2530.73%
5.32
Capital Expenditure
-0.76
+5.15%
-0.80
+45.63%
-1.46
+25.95%
-1.98
Capital Expenditure Reported
-0.75
+5.19%
-0.79
+45.02%
-1.44
-4.43%
-1.38
Net Investment Purchase And Sale
85.22
+162.92%
32.41
+121.72%
-149.20
0.00
Purchase Of Investment
-0.00
+100.00%
-284.31
+25.57%
-382.01
0.00
Sale Of Investment
85.22
-73.09%
316.73
+36.05%
232.81
0.00
Net Business Purchase And Sale
-58.22
0.00
0.00
-100.00%
7.30
Purchase Of Business
-58.22
0.00
0.00
—
Gain Loss On Sale Of Business
—
0.00
0.00
+100.00%
-12.24
Net Intangibles Purchase And Sale
-0.01
+0.00%
-0.01
+77.78%
-0.03
+95.51%
-0.60
Purchase Of Intangibles
-0.01
+0.00%
-0.01
+77.78%
-0.03
+95.51%
-0.60
Net Other Investing Changes
-0.00
—
21.28
—
Financing Cash Flow
1.50
+104.34%
-34.41
-3212.03%
-1.04
+79.14%
-4.98
Cash Flow From Continuing Financing Activities
1.50
+104.34%
-34.41
-3212.03%
-1.04
+79.14%
-4.98
Net Issuance Payments Of Debt
-4.25
+87.66%
-34.39
-751.73%
-4.04
-21.96%
-3.31
Issuance Of Debt
0.00
-100.00%
104.54
0.00
0.00
Repayment Of Debt
-4.25
+96.94%
-138.93
-3340.61%
-4.04
-21.96%
-3.31
Long Term Debt Issuance
0.00
-100.00%
104.54
0.00
0.00
Long Term Debt Payments
-4.25
+96.94%
-138.93
-3340.61%
-4.04
-21.96%
-3.31
Net Long Term Debt Issuance
-4.25
+87.66%
-34.39
-751.73%
-4.04
-21.96%
-3.31
Net Common Stock Issuance
—
—
—
2.28
Cash Dividends Paid
0.00
0.00
0.00
0.00
Proceeds From Stock Option Exercised
19.81
+255.14%
5.58
-31.40%
8.13
+256.55%
2.28
Net Other Financing Charges
-7.88
—
—
—
Changes In Cash
82.45
+1896.77%
-4.59
+96.89%
-147.73
-747.96%
22.80
Effect Of Exchange Rate Changes
7.91
+458.11%
-2.21
-203.76%
2.13
+128.83%
-7.38
Beginning Cash Position
54.94
-11.01%
61.74
-70.22%
207.34
+8.03%
191.92
End Cash Position
145.31
+164.46%
54.94
-11.01%
61.74
-70.22%
207.34
Free Cash Flow
53.95
+2182.32%
-2.59
+86.19%
-18.77
-191.63%
20.48
Common Stock Issuance
—
—
—
2.28
Earnings Losses From Equity Investments
-0.62
-135.44%
1.76
+508.30%
0.29
-73.31%
1.08
Interest Paid CFF
-6.20
-10.70%
-5.60
-9.04%
-5.13
-29.91%
-3.95
Interest Received CFO
2.07
-60.22%
5.20
+80.40%
2.88
+3291.76%
0.09
Issuance Of Capital Stock
—
—
—
2.28
Sale Of Business
—
0.00
0.00
-100.00%
7.30
Taxes Refund Paid
-4.60
+70.49%
-15.58
-2279.24%
-0.66
+46.96%
-1.24
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category